advertisement

Topcon

Serle JB 13

Showing records 1 to 13 | Display all abstracts from Serle JB

80619 Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
Khouri AS
American Journal of Ophthalmology 2019; 204: 97-104
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Asrani S; Robin AL
American Journal of Ophthalmology 2019; 207: 248-257
80619 Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
Serle JB; Bacharach J
American Journal of Ophthalmology 2019; 204: 97-104
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Serle JB
American Journal of Ophthalmology 2019; 207: 248-257
80619 Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
Usner DW
American Journal of Ophthalmology 2019; 204: 97-104
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Lewis RA
American Journal of Ophthalmology 2019; 207: 248-257
80619 Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
Lewis RA
American Journal of Ophthalmology 2019; 204: 97-104
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Usner DW; Kopczynski CC
American Journal of Ophthalmology 2019; 207: 248-257
80619 Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
Braswell P
American Journal of Ophthalmology 2019; 204: 97-104
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial
Heah T
American Journal of Ophthalmology 2019; 207: 248-257
80619 Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study
Kopczynski CC; Heah T
American Journal of Ophthalmology 2019; 204: 97-104
81324 Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: 3-Month Data From a Randomized Phase 3 Trial

American Journal of Ophthalmology 2019; 207: 248-257
80619 Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

American Journal of Ophthalmology 2019; 204: 97-104

Issue 20-3

Change Issue


advertisement

Oculus